Listen to the podcast. Find it on iTunes. Download the transcript. Sponsor: HealthPay24.
Dana Gardner: Hi, this
is Dana Gardner,
Principal Analyst at Interarbor
Solutions, and you’re listening to BriefingsDirect. Our next healthcare
finance insights discussion explores the impacts from increased cost
transparency for medical services.
Gardner |
The recent required publishing
of hospital
charges for medical procedures is but one example of rapid regulatory and
market changes. The emergence of more data about costs across the health
provider marketplace could be a major step toward educated choices – and
ultimately more efficiency and lower total expenditures.
But early-stage cost
transparency also runs the
risk of out-of-context information that offers little actionable insight
into actual consumer costs and obligations. And unfiltered information
requirements also place new burdens on physicians, caregivers, and providers –
in areas that have more to do with economics than healthcare.
To learn more about the pluses
and minuses of increased costs transparency in the healthcare sector, we are
joined by our expert panel:
- Heather Kawamoto, Chief Product Officer at Recondo Technology in Denver.
- Joann Barnes-Lague, Revenue Cycle Director at Shields Health Care Group in Quincy, Mass.
- Julie Gerdeman, President at HealthPay24 in Mechanicsburg, Penn.
- Beth Jones Sanborn, Managing Editor at Healthcare Finance News/HIMSS Media in Portland, Maine.
- Alena Harrison, Senior Director of PBM Innovation at CVS Health in Woonsocket, RI.
Welcome to you all. For better or worse, we are well into an era of new transparency about medical costs. Heather, why is transparency such a hot issue right now?
Kawamoto |
Kawamoto: It’s
largely due to a cost shift. Insurance companies are having patients owe more
of a payment’s portion. With that there has been a significant rise in the high-deductible
health plans -- not only in the amount of the deductible, but also in the
number of patients on high-deductible plans.
And when patients
get, sadly, more surprise bills, we start to hear about it in the media. We also have the onset this month of the IPPS/LTCH PPS final rule from the Centers for Medicare and Medicaid Services (CMS) [part
of the U.S. Department of Health and Human Services].
The New York Times did
a recent story about this, and that’s created buzz.
And then people start saying, “Hey, I know I have a medical service coming up, I
probably need to call in and actually find out how much my service is going to
be.”
Gardner: It
seems like the consumer, the patient, needs to be far more proactive in
thinking about their care, not just in terms of, “Oh, how do I get better? Or
how do I stay as healthy as I can?” But in asking, “How do I pay for this in
the best possible way?”
That economic component wasn't
the case that long ago. You would get care and you didn't give much thought to price
or how it was billed.
Joann, as somebody who
provides care, what’s changed that makes it necessary for patients to be
proactive about their health economics?
Know before you owe
Barnes-Lague |
Barnes-Lague: It’s
the consumer-driven health plans, where patients are now responsible for more.
They have to make a decision – “Do I buy my groceries, or do I have an MRI.”
The shift in healthcare makes
us go after the patient before insurance is paid 100 percent. Patients now have
a lot of skin in the game. And they have to start thinking, “Do I really need
this procedure, or can it wait?”
Gardner: And we
get this information-rush from other parts of our lives. We have so much more
information available to us when we buy groceries. If we do it online, we can
compare and contrast, we can comparison shop, we can even get analysis brought
to the table. It can be a good thing.
Julie, you are trying to help
people make better paying decisions. If we have to live with more cost transparency,
how can technology be a constructive part of it?
Gerdeman |
Gerdeman: It's
actually a tremendous opportunity for technology to help patients and providers.
We live in an experience
economy, and in that economy everyone is used to having full
transparency. We’re willing to pay for faster service, faster delivery.
We have highly personalized experiences.
And all of that should be the same in our healthcare experiences. This is what people
have come to expect. And that's why, for us, it’s so important to provide
personalized, consumer-friendly digital payment options.
Sanborn: As someone
who has been watching these high-deductible health plans unfold, data has come
out saying the average American household can't afford a $500 medical bill, that
an unexpected $500 medical bill would drastically impact that household’s
finances for months. So people are looking to understand upfront what they are
going to owe.
At the same time, patients are
growing tired of the back-and-forth between the provider and the payer, with everyone
kicking the can back and forth between then saying, “Well, I don’t know that. Your
provider should know that.” And the provider says, “Well, your health plan is
the one that arbitrates the price of your care. Why don't you go ask them?” Patients
are getting really, really tired of that.
That’s why we are seeing the
rise in urgent
care centers, walk-in clinics, and places where they don’t have to wait.
They can instead book an appointment on their phone and go to the appointment
20 minutes later. Patients have the opportunity to pick where they get their
care and they know it. At the same time, they know they can demand transparency
because it's time.
Gardner: So transparency
can be a force for good. It can help people make better decisions, be more
efficient, and as a result drive their cost down. But transparency can put too
much information in front of people, perhaps at a time when they are not really
in a mindset to absorb it.
What are you doing at CVS, Alena,
to help people make better decisions, but not overload them?
Clear information increases options
Harrison |
Harrison: The
key to good transparency tools is that they have to be a 100 percent accurate.
Secondly, the information has to be clear, actionable, and relevant to the patient.
If we gave patients 10 data points
about the price of a drug -- and sometimes there are 10 prices depending on how
you look at it -- it would overwhelm folks. It would confuse them, and we could
lose that engagement. Providing simple, clear data that is accurate and actionable
shows them the options specific to their benefit plan. That is what we can do
to help consumers navigate through this very complex web in our healthcare
system.
Gardner: Recondo
helps people create and deliver estimates throughout this process. How does
that help in providing the right information, at the right time, in the right context?
Kawamoto: It's
critical to provide [estimate information] when a patient schedules their
service, because that gives them the opportunity -- if there is a financial
question or concern -- to say, “Okay, I don’t know that I can pay for that. Is
there another location where the price might be different? What are my
financial options in terms of the payment plan or some sort of assistance?”
Enabling providers to
proactively communicate that information to patients as they schedule a service
or in advance gives patients an opportunity to shop. They know they are going
to be meeting with an orthopedic surgeon because they need knee arthroscopy.
In advance of that, they
should be able to get some idea of what they are going to owe, relative to
their specific benefit information. It puts them in that position to engage
with the orthopedic surgeon to say, “I looked at the facility and it's actually
going to be $3,000. What are my options?” Now, that provider can be a part of
the cost discussion. I think that is critical.
Barnes-Lague: As
providers we have to be okay with patients making that decision, of saying, “Maybe
I won’t have that service now.” That’s consumer-driven. And sometimes that hurts
our volume.
We may have had a hard time
understanding that in the beginning, when we shared estimates and feared that the
patients wouldn't come. Well, would you rather trick them and then have bad
debt?
As
providers we have to be okay with patients making that decision, of saying, "Maybe I won't have that service right now." That's consumer-driven. ... It's about being comfortable with the patient making educated decisions.
It’s about being comfortable with the patient making educated decisions. Perhaps they will come back for your MRI in December when their deductibles are met, and they can better afford it.
Gardner: Part
of this solution requires the physician or practitioner to be educated enough
to help the patient sort out the finances, as well as the care and medical
treatments. As someone who has a lot of clinicians, technicians, and physicians,
are they not the primary point for more transparency to the patient?
Barnes-Lague: That would
be the ideal solution, to have the physicians who are referring these very
expensive services to begin having those conversations. Often patients are kind
of robotic with what their doctors tell them.
We have to tell them, “You
have a choice. You have a choice to make some phone calls. You have a choice to
do your own price shopping.” We would love it if the referring physicians began
having those price-transparency conversations early, right in their offices.
Gardner: So the
new dual-major: Economics and pre-med?
Julie, your background is in
technology. You and I both know there are lots of occupations where people have
complex decisions to make. And they have to be provided trust and accommodation
to make well-informed decisions.
Whether you are a purchasing
agent, chief executive, or chief marketing officer, there are tools and data to
help you. There have been great strides made in solving some of these problems.
Is that what we are going to see applied to these medical decisions across the
spectrum of payer, provider, and patient?
Easy-to-access, secure data builds trust
Gerdeman: This field
is ripe for disruption. And technology, particularly emerging technology, can
make a big difference in providing transparency.
A lot of my colleagues here have
talked about trust. To me, the reason everybody is requiring transparency is to
build trust. It goes back to that trusted relationship between the provider and
the patient.
The data should be available to
everyone. It’s now time to present the data in a very clear, simple, and actionable
way for them to make decisions. The consumer can make an informed decision, and
the provider can know what the consumer is facing.
Gardner: Yet
to work, that data needs to be protected. It needs to adhere to multiple
regulations in multiple jurisdictions, and compliance is a moving target
because the regulations change so often.
Beth, what do we do to solve
the data availability problem? Everybody knows data is how to solve it. It’s about
more data. But nobody wants to own and control that data.
Sanborn: Yes,
it’s the $64,000 question. How do you own all that data and protect it at the
same time? We know that healthcare is one of the most attacked industries when
it comes to cyber criminals, ransomware, and phishing.
Sanborn |
I hear all the time from
experts that as much as the human element drives healthcare, as far as data and
its protection [the human element] is also the greatest vulnerability. Most of
the attacks you hear about happen because someone clicked on a link in an email
or left their laptop somewhere. These are basic human errors that can have
catastrophic consequences depending on who is on the receiving end of that
error.
Technology is, of course, a
huge part of the future, but you can't let technology develop faster than the
protections that have to go with it. And so any developer, any innovator who is
trying to help move this space forward has to make cybersecurity a grassroots
foundational part of anything that they innovate.
It’s not enough to say, “My
tool can help you do this, this, and this.” You have to be able to say, “Well,
my tool will help you do this, this, and this, and this is how we are
going to protect you along the way.” That has to be part of, not just the
conversation, but every single solution.
Gardner: Alena,
at CVS, do you see that data solution as a major hurdle to overcome? Meaning
the controlling, managing, and protection of the data -- but also making it
available to every nook and cranny that it needs to get to?
Harrison: That’s
always a key focus for us, and it’s frankly ingrained in every single thing we
do. To give a sense of what we are putting out there, the price transparency
tools that we have developed are all directly connected to our claims system.
It’s the only way we can make sure that the patient out-of-pocket costs we provide
are 100 percent accurate. They must reflect what that patient would pay as they
go to their local pharmacy.
Gardner: So we
have a lot going on with new transparency regulations, and more information
coming out. We know that we have to make it secure, and we are going to have to
overcome that. So it’s early still.
It seems to me, though, there
are examples of the tools already developed and how they can be impactful; they
can work.
Joann at Shields, do you have any
examples of what benefits can happen when you bring in the right tools for transparency
and for making good decisions?
Transparency upfront benefits bottom line
Barnes-Lague: Yes,
we bring in more revenue and we bring it in timely. We used to be at about 60
percent collected from the patient’s side overall. Since we implemented tools, we
are at 85 percent collected, a 400 percent increase in our overall revenue.
We have saved $4.5 million in [advance
procedure] denials, just based on eligibility, authorization, and things like
that. We are bringing in more money and we don’t require as much labor because of
the automation. We are staffed around the automation now.
Gardner: Julie,
how does it work? How do better tools and more information in advance help
collect more money for a medical transaction?
Gerdeman: It
works in a couple of ways. First, from a patient-facing perspective, they have the
access to pay whenever and wherever they are. Having that access and
availability is critical.
We have saved $4.5 million in [advance procedure] denials -- just based on eligibility, authorization, and things like that. We are bringing in more money and we don't require as much labor because of the automation.
Also they need to be connected. An estimate – like Heather talked about, to be able to make a decision from that -- has to be available from the very beginning.
And then finally, it's about options.
All of these things help drive adoption if you give a patient options and
clarity upfront. They have a choice of how to pay and they have the knowledge about
costs. That adoption drives success.
So if you implement the tools
appropriately you will see immediate impact. The patients adopt it, the staff adopts
it, and then it drives up the collections that Joann is talking about.
Gardner: Heather,
we have seen in other industries that tracking decision processes and behaviors
leads to understanding use patterns. From them, incentivization can come into play.
Have you seen that? How can incentives and transparency improve the overall
economic benefits?
Incentivization improves savings
Kawamoto: Being
able to communicate to patients what their anticipated out-of-pocket costs will
be is powerful. A lot of organizations have created the means where they say to
the patient, “If you pay this amount in advance of your service, you will
actually get a discount.” That puts the patient in a position to
say, “I could save $200 if I decide to pay this today.” That's a key component of
it. They know they are going to get a better cost if they pay sooner, and then
many of them are incented to do that.
Gardner: Any
other thoughts about incentives, Alena?
Harrison: Yes.
An indirect incentive, but still quite relevant, is that our price transparency
tools are available to all of our CVS Caremark members. We
are seeing about 230,000 searches a month on our website.
When members search for the
drugs they are taking, if there are lower-cost alternative options, we see
members in their next refill order one of those lower cost drugs 20 percent of
the time. That results in an average savings of $120 per prescription fill for
those patients. As you can imagine, over the course of several months, that
savings really starts to add up.
Gardner: We have
come back to the idea of the out-of-pocket costs. The higher the deductible, the
lower the premiums. People are incentivized therefore to go to lower premiums. But
then, heaven forbid, they have an illness, and then they have to start thinking
about, “Oh my gosh, how do I best manage that out-of-pocket deductible?”
Nowadays, with technologies
like machine learning
(ML), artificial
intelligence (AI), and big
data analytics, we are seeing prescriptive or even recommendation types of
technologies. How far do we need to go before we can start to bring some of those
technologies about making good recommendations based on data -- rather than
intuition or even a lack of informed decision making — to medical finance
decisions? How do we get to that point where we can be proscriptive in automated
recommendations, rather than people slogging through this by themselves?
Automated advice advances
Gerdeman: At HealthPay24
we are looking at predictive analytics and what role the predictive capability
can play in helping make recommendations for patients. That’s not necessarily
on the clinical or pharmaceutical side, but we know when a patient makes an
appointment and gets an estimate what their propensity to pay will be.
Proactively we can offer them options
based on what we know ahead of time. They don't even have to worry about it. They
can just say, “Okay, here are my choices. I have only saved up $500; therefore,
I am going to take advantage of a loan or a payment plan.” And I do believe
that technology will help.
On the AI side, it’s already starting.
As you talk to providers, they are using it for repetitive processes. But I
think there is even more opportunity on the cognitive side of AI to play [a
role] in hospitals. So there is a big opportunity.
Gardner: We already see this in financial markets. People get more information, they get recommendations, and there is arbitrage. It’s not either/or. It’s what are the circumstances? What’s the credit we can offer? How do we make the most efficient transaction for all parties?
So, as in other transactions, we
have to gain more comfort with the combination economics and medical procedures.
Is that part of the culture shift? You have to be a crass consumer and you
have to be looking out for your health.
Any thoughts about the need to
be both a savvy consumer as well as a patient?
Kawamoto: It's critical.
To Julie’s point, we are now looking through our data and finding legitimate
savings opportunities for patients, and we’re proactively outreaching to those
patients. Of course, at the end of the day, the decision is always in the
provider’s hands -- and it should be, because not all of us are clinicians. I certainly
am not. But to allow patients to prompt that fuller conversation helps drive
the process, so the burden isn't just on the provider. This is critical.
Gardner: Before
we close out, any recommendations? How should the industry best prepare for
more transparency around procedures and payments in medical environments? Joann,
what do you think people should be thinking about to better prepare themselves
as providers for this new era of transparency?
Lead with clear communication
Barnes-Lague: Culture
is very important within the organization. You need to continue to talk. It’s
shifting. Let’s talk about the burden to the provider, now that the patients
are responsible for more. There is no other product that you can purchase
without paying upfront. But you can walk away from healthcare without paying
for it.
The more technology
you implement, the more transparency you can provide, the more conversations
you can have with those patients – these not only help the patients. You as
providers are in business for revenue. This helps bring in the revenue that you
have lost with the shift to consumer-driven health plans.
Gardner: Heather,
as someone who provides tools to providers, what should they be thinking about
when it comes to a new era of transparency?
That’s what providers need to
be thinking about. How do I get even further out into the decision-making
process? How do we engage with that patient at that early point, which is going
to build trust, as well as ensure that revenue is coming to your particular facility?
Gardner: Beth,
what advice do you have for consumers, the patients? What should they be
thinking about to take advantage of transparency?
Take care of physicians and finances
Sanborn: First,
I want to advocate for the physicians. We hear all the time about change
fatigue, burnout; burnout
is as hot a topic as transparency. If providers are going to be put in the position
of having to have financial conversations with patients, I think health system
leaders need to be aware of that and make sure that providers are properly
educated. What do they need to know so that they can accurately communicate
with patients? And they need to understand how that's going to affect the
workload -- that is already onerous and at times damaging -- to physicians. So
along Joann’s comments about culture, there needs to be a culture around
ushering in physicians into that role.
From a consumer standpoint,
when we look at the
law that just went into effect, patients need to understand what are they
looking at. The price list that the hospital is publishing is a chargemaster. It’s a naked
price from a hospital. It's not what they are going to pay, and so we need to
eradicate the sticker shock that I am sure is happening at first glance.
Gardner: The
patient needs to self-educate about what’s net-net and what’s gross when it
comes to these prices?
Patients need to be educated on what they are looking at, and then understand the options available to them as far as what they are actually going to pay. Payers need to make sure they are reaching out and make sure their consumers understand how the benefits work.
Sanborn: Right. You can put these prices in plain terms. The chargemaster is what a hospital charges. But remember you have insurance. There are discounts for self-pay. There could be other incentives or subsidies that you are eligible for.
So please don't have a heart
attack, literally, when you look at this price and go, “Oh, my gosh, is that
what I am responsible for?” Patients need to be educated on what they are
looking at, and then understand the options available to them as far as what
you are actually going to pay.
And the other thing is
benefits literacy. Payers need to make sure they are reaching out to their
consumers and making sure their consumers understand how the benefits work so
that they can advocate for themselves.
Gardner: Alena
at CVS, as a provider of pharmaceutical services and goods, what advice do you
have about making the best of transparency?
Harrison: Beth
hit the nail on the head with a lot of her points. We see similar brute-force
regulation happening in the prescription drug space. So pharmaceutical
manufacturers now need to publish their “sticker” prices.
Little do most people know, the
sticker price is something no one pays. Payers don't pay it. Patients certainly
don't pay it. The pharmacy doesn’t pay it. And so it is so critical as this
information becomes available to make sure that your customers, consumers, and members
understand what they are looking at. You as an organization should be prepared
to support them through the process of navigating this additional information.
Gardner:
Julie, what should people be thinking about on the vendor side, the people
providing these tools, now that transparency is a necessary part of the process?
What should the tool providers be thinking about to help people navigate this?
Gerdeman: It
comes back to the user experience -- providing a simple, clear, and consumer
friendly experience through the tools. That is what’s going to drive usage, adoption,
and loyalty.
Anything we can do in the
tools themselves to be predictive, clear, beautiful, and simple will make all
the difference.
Gardner: I am
afraid that we will have to leave it there. You have been listening to a
sponsored BriefingsDirect digital business innovation podcast on the emergence
of more data about costs across the health provider marketplace.
And we have learned about the
pluses and minuses of increased costs transparency in the healthcare sector and
ways to reduce the risk of out-of-context information that offers little
actionable insight into actual consumer costs and obligations.
So please join me now in
thanking our guests, Heather Kawamoto, Chief Product
Officer at Recondo Technology in Denver; Joann Barnes-Lague, Revenue Cycle
Director at Shields Health Care Group in Quincy, Mass.; Julie Gerdeman,
President at HealthPay24 in Mechanicsburg, Penn.; Beth Jones Sanborn,
Managing Editor at Healthcare Finance News/HIMSS Media in Portland, Maine,
and Alena Harrison, Senior Director of PBM Innovation at CVS Health
in Woonsocket, RI.
And a big thanks to our
audience for joining this HealthPay24-sponsored thought leadership discussion.
I’m Dana Gardner, Principal Analyst at Interarbor Solutions, your host and
moderator. Thanks again for listening, and do come back next time.
Listen to the podcast. Find it on iTunes. Download the transcript. Sponsor: HealthPay24.
Transcript of a discussion on how new transparency on costs in healthcare provides both a step toward more educated choices as well as an opportunity to use technology to inform and instruct throughout increasingly complex payer-provider-patient processes. Copyright Interarbor Solutions, LLC, 2005-2019. All rights reserved.
You may also be
interested in:
- How The Open Group Healthcare Forum and Health Enterprise Reference Architecture cures process and IT ills
- Philips teams with HPE on ecosystem approach to improve healthcare informatics-driven outcomes
- A tale of two hospitals—How healthcare economics in Belgium hastens need for new IT buying schemes
- IT kit sustainability: A business advantage and balm for the planet
- How global HCM provider ADP mines an ocean of employee data for improved talent management
- The Open Group panel explores ways to help smart cities initiatives overcome public sector obstacles
- Regional dental firm Great Expressions protects distributed data with lower complexity thanks to amalgam of Nutanix HCI and Bitdefender security
- Balancing costs with conscience--How new tools help any business build ethical and sustainable supply chains
No comments:
Post a Comment